Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rashYuki Ichimura, Naoko Okiyama, Risa Konishi et al.|Lara D. Veeken|2021Cited by 61
Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6Ryota Tanaka, Naoko Okiyama, Yuki Ichimura et al.|Communications Biology|2020Cited by 52
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositisNaoko Okiyama, Manabu Fujimoto, Yuki Ichimura et al.|Annals of the Rheumatic Diseases|2021Cited by 47
Differential Involvement of Programmed Cell Death Ligands in Skin Immune ResponsesRyota Tanaka, Naoko Okiyama, Noriko Kubota et al.|Journal of Investigative Dermatology|2021Cited by 38
Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in JapanWataru Sasaki, Mariko Sugawara‐Mikami, Kazunari Sugita et al.|The Journal of Dermatology|2025Cited by 8